The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Intec Pharma announced that the last patient has completed their final visit in the Company's trial evaluating the safety and efficacy of the ...
read more
Biohaven has enrolled the first patient in a Phase 2/3, double-blind, randomized, placebo-controlled, dose-ranging trial of intranasally administered ...
read more
Breath Therapeutics announced the initiation of the Phase 3 BOSTON clinical studies of L-CsA-i for the treatment of Bronchiolitis Obliterans Syndrome ...
read more
Teva announced the launch of a generic version of EXJADE® (deferasirox) Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg, in the U.S.
read more
Candel announced the treatment of the first high grade glioma patients in a study of its GMCI™ in combination with the checkpoint inhibitor nivolumab ...
read more
The FDA approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women.
read more
Wednesday, March 20, 2019
Nordic Group and Primex Pharmaceuticals AG have announced a strategic agreement today to launch OZALIN® in France.
read more
Hospira is voluntarily recalling several lots of Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL), to the Hospital/Institution level.
read more
Mylan is conducting a voluntary nationwide recall of two lots of Levoleucovorin Injection, 250 mg/25 mL tothe consumer/user level.
read more
Wednesday, March 13, 2019
CURE has broadened its DEA license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic CBD.
read more
Wednesday, March 06, 2019
The FDA has approved Spravato nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have treatment-...
read more
Eli Lilly and Company announced the company will introduce a lower-priced version of Humalog® (insulin lispro injection 100 units/mL) in the United ...
read more
Novo Nordisk announced it recently submitted label updates to the EMA and the FDA for Fiasp® 100 u/mL, seeking approval for use as a new mealtime ...
read more
Thursday, February 28, 2019
ICU Medical has announced a voluntary recall of certain lots of ChemoLock™ and ChemoClave® Vial Spikes due to the potential for burr particulate ...
read more
Thursday, February 28, 2019
The first human study of a pill designed to replace injections of biologics is today being announced by Rani Therapeutics, the inventor of the ...
read more